The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Review the latest news and information on the COVID-19 Pandemic.
read more
Wednesday, April 08, 2020
Care Access Research is leading a validation trial in conjunction with the FDA for a new at-home COVID-19 test developed by a private genomics lab ...
read more
Wednesday, April 08, 2020
Review the latest news and information on the COVID-19 Pandemic.
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
Biomerica has signed two separate definitive license agreements with Mount Sinai’s Icahn School of Medicine to license a serological test for SARS-CoV...
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
Wednesday, April 01, 2020
The FDA stood up a new program to expedite the development of potentially safe and effective life-saving treatments.
read more
AstraZeneca Pharmaceuticals
AstraZeneca will collaborate with Silence Therapeutics to discover, develop and commercialize siRNA therapeutics for Cardiovascular, Renal, Metabolic ...
read more
Novartis and a consortium of life sciences companies announced a collaboration to accelerate the development, manufacture and delivery of vaccines, ...
read more
At the direction of the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense, the Medical CBRN Defense ...
read more
INTERPHEX announced the postponed events will take place on July 15-17, 2020 at the Javits Center in New York City.
read more
Wednesday, March 11, 2020
International Pharmaceutical Expo (INTERPHEX) will be postponed due to the COVID-19 virus.
read more
F2G announced the FDA has granted ODD to its lead first-in-class candidate, olorofim for invasive aspergillosis and for treatment of lomentospora/...
read more
Wednesday, February 26, 2020
CPhI Japan has announced the event will be postponed until a new date later in the year after consultation with key stakeholders and consideration of ...
read more